Merry Life Biomedical Company, Ltd.
- Biotech or pharma, therapeutic R&D
Merry Life Biomedical is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of neurodegenerative diseases. The company is developing TML-6, an innovative oral, disease-modifying therapy for early Alzheimer’s disease. By targeting the upstream inflammatory pathways believed to drive disease progression, TML-6 aims to change the course of Alzheimer’s while offering a treatment that is more accessible, affordable, and safer for patients and healthcare systems.
Address
TainanTaiwan
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}